International Clinical Trial: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Study to Evaluate the Efficacy and Safety of Sitokiren Malate Tablets Combined with Amlodipine Besylate Tablets in the Treatment of Patients with Primary Mild to Moderate Hypertension Complicated with Risk of Early Renal Injury

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133505) titled 'A Multicenter, Randomized, Double-Blind, Parallel-Controlled Study to Evaluate the Efficacy and Safety of Sitokiren Malate Tablets Combined with Amlodipine Besylate Tablets in the Treatment of Patients with Primary Mild to Moderate Hypertension Complicated with Risk of Early Renal Injury' on Sept. 28.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: primary mild to moderate hypertension

Intervention: Active Drug Control Group:Sitokiren Malate Tablets Placebo Allisartan Isoproxil Tablets Amlodipine Besyl...